Please enable JavaScript to continue using this application.

Compare $DTIL vs $ELDN | Chartloom

Compare

$DTIL vs $ELDN

Precision BioSciences Inc · Eledon Pharmaceuticals Inc

DTIL

Precision BioSciences Inc

ELDN

Eledon Pharmaceuticals Inc

Compare $DTIL vs $ELDN

Comparing Precision BioSciences Inc and Eledon Pharmaceuticals Inc

DTILPrecision BioSciences Inc

ELDNEledon Pharmaceuticals Inc

DTILPrecision BioSciences Inc

Market cap

$173M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

80.94x

Rev growth (TTM)

3473.0%

YTD performance

63.9%

52W performance

17.9%

FCF yield

-30.2%

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DTIL

ELDN

Detailed metrics comparison

DTIL

Precision BioSciences Inc

ELDN

Eledon Pharmaceuticals Inc

Market Cap

DTIL$173M

ELDN$191M

Enterprise Value

DTIL$110M

ELDN$185M

Price

DTIL$6.72

ELDN$2.48

P/E Ratio

DTILN/A

ELDNN/A

P/S Ratio

DTIL3.85x

ELDN0.00x

EV/Sales

DTIL2.44x

ELDN0.00x

EV/EBITDA

DTIL0.00x

ELDN0.00x

P/B Ratio

DTIL3.85x

ELDN2.81x

P/FCF Ratio

DTILN/A

ELDNN/A

EV/FCF

DTIL-2.09x

ELDN-2.50x

PEG Ratio

DTILN/A

ELDNN/A

Forward P/E (NTM)

DTILN/A

ELDNN/A

Forward P/S (NTM)

DTIL80.94x

ELDNN/A

Revenue (TTM)

DTIL$45M

ELDN$0

Revenue Growth (YoY)

DTIL3473.0%

ELDNN/A

Forward Rev Growth

DTIL-28.2%

ELDN325.8%

Gross Margin (TTM)

DTIL0.0%

ELDN0.0%

Operating Margin (TTM)

DTIL0.0%

ELDN0.0%

EBITDA Margin (TTM)

DTIL-78.0%

ELDN0.0%

Net Margin (TTM)

DTIL-117.0%

ELDN0.0%

FCF Margin (TTM)

DTIL-116.3%

ELDNN/A

Net Income (TTM)

DTIL$-53M

ELDN$-99M

FCF (TTM)

DTIL$-52M

ELDN$-74M

EPS (TTM)

DTIL-$2.04

ELDN-$0.87

ROE (TTM)

DTIL-9160.0%

ELDN-9848.0%

ROA (TTM)

DTIL-4074.0%

ELDN-6897.0%

ROIC (TTM)

DTIL-6594.0%

ELDN-9848.0%

Cash

DTIL$86M

ELDN$7M

Debt

DTIL$22M

ELDN$0

Net Cash/Debt

DTIL$64M

ELDN$7M

Current Ratio (TTM)

DTIL12.82x

ELDN7.90x

Quick Ratio (TTM)

DTIL12.26x

ELDN7.60x

Debt/Equity (TTM)

DTIL0.50x

ELDN0.00x

Debt/Assets (TTM)

DTIL0.0%

ELDN0.0%

Interest Coverage (TTM)

DTILN/A

ELDNN/A

Net Debt/EBITDA (TTM)

DTIL0.00x

ELDN0.00x

Beta

DTIL1.44

ELDN1.01

52W Performance

DTIL17.9%

ELDN-13.6%

YTD Performance

DTIL63.9%

ELDN53.1%

% from 52W High

DTIL-30.1%

ELDN-46.1%

% from 52W Low

DTIL90.4%

ELDN83.7%

Asset Turnover (TTM)

DTIL0.36x

ELDN0.00x

FCF Yield (TTM)

DTIL-30.2%

ELDN-38.6%

Earnings Yield (TTM)

DTIL-30.4%

ELDN-51.5%

Dividend Yield (TTM)

DTILN/A

ELDNN/A

Rule of 40

DTIL3,356.7

ELDN0.0

EV/GP/RG

DTILN/A

ELDNN/A

Ticker research

View DTIL research View ELDN research

Metric	DTIL Precision BioSciences Inc	ELDN Eledon Pharmaceuticals Inc
Market & Valuation
Market Cap	$173M	$191M
Enterprise Value	$110M	$185M
Price	$6.72	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	3.85x	0.00x
EV/Sales	2.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.85x	2.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.09x	-2.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	80.94x	N/A
Revenue & Growth
Revenue (TTM)	$45M	$0
Revenue Growth (YoY)	3473.0%	N/A
Forward Rev Growth	-28.2%	325.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-78.0%	0.0%
Net Margin (TTM)	-117.0%	0.0%
FCF Margin (TTM)	-116.3%	N/A
Net Income (TTM)	$-53M	$-99M
FCF (TTM)	$-52M	$-74M
EPS (TTM)	-$2.04	-$0.87
ROE (TTM)	-9160.0%	-9848.0%
ROA (TTM)	-4074.0%	-6897.0%
ROIC (TTM)	-6594.0%	-9848.0%
Financial Health
Cash	$86M	$7M
Debt	$22M	$0
Net Cash/Debt	$64M	$7M
Current Ratio (TTM)	12.82x	7.90x
Quick Ratio (TTM)	12.26x	7.60x
Debt/Equity (TTM)	0.50x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.01
52W Performance	17.9%	-13.6%
YTD Performance	63.9%	53.1%
% from 52W High	-30.1%	-46.1%
% from 52W Low	90.4%	83.7%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-30.2%	-38.6%
Earnings Yield (TTM)	-30.4%	-51.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,356.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DTIL research	View ELDN research

Valuation

P/S Ratio

ELDN

0.00x

DTIL

3.85x

EV/FCF

ELDN

-2.50x

DTIL

-2.09x

Growth & revenue

Revenue Growth TTM

DTIL

3473.0%

Forward Revenue Growth

ELDN

325.8%

DTIL

-28.2%

Profitability & performance

Gross Margin

DTIL

0.0%

ELDN

0.0%

ROE

DTIL

-9160.0%

ELDN

-9848.0%

FCF Yield %

DTIL

-30.2%

ELDN

-38.6%

52-Week Performance

DTIL

17.9%

ELDN

-13.6%

Detailed metrics comparison

DTIL

Precision BioSciences Inc

ELDN

Eledon Pharmaceuticals Inc

Market Cap

DTIL$173M

ELDN$191M

Enterprise Value

DTIL$110M

ELDN$185M

Price

DTIL$6.72

ELDN$2.48

P/E Ratio

DTILN/A

ELDNN/A

P/S Ratio

DTIL3.85x

ELDN0.00x

EV/Sales

DTIL2.44x

ELDN0.00x

EV/EBITDA

DTIL0.00x

ELDN0.00x

P/B Ratio

DTIL3.85x

ELDN2.81x

P/FCF Ratio

DTILN/A

ELDNN/A

EV/FCF

DTIL-2.09x

ELDN-2.50x

PEG Ratio

DTILN/A

ELDNN/A

Forward P/E (NTM)

DTILN/A

ELDNN/A

Forward P/S (NTM)

DTIL80.94x

ELDNN/A

Revenue (TTM)

DTIL$45M

ELDN$0

Revenue Growth (YoY)

DTIL3473.0%

ELDNN/A

Forward Rev Growth

DTIL-28.2%

ELDN325.8%

Gross Margin (TTM)

DTIL0.0%

ELDN0.0%

Operating Margin (TTM)

DTIL0.0%

ELDN0.0%

EBITDA Margin (TTM)

DTIL-78.0%

ELDN0.0%

Net Margin (TTM)

DTIL-117.0%

ELDN0.0%

FCF Margin (TTM)

DTIL-116.3%

ELDNN/A

Net Income (TTM)

DTIL$-53M

ELDN$-99M

FCF (TTM)

DTIL$-52M

ELDN$-74M

EPS (TTM)

DTIL-$2.04

ELDN-$0.87

ROE (TTM)

DTIL-9160.0%

ELDN-9848.0%

ROA (TTM)

DTIL-4074.0%

ELDN-6897.0%

ROIC (TTM)

DTIL-6594.0%

ELDN-9848.0%

Cash

DTIL$86M

ELDN$7M

Debt

DTIL$22M

ELDN$0

Net Cash/Debt

DTIL$64M

ELDN$7M

Current Ratio (TTM)

DTIL12.82x

ELDN7.90x

Quick Ratio (TTM)

DTIL12.26x

ELDN7.60x

Debt/Equity (TTM)

DTIL0.50x

ELDN0.00x

Debt/Assets (TTM)

DTIL0.0%

ELDN0.0%

Interest Coverage (TTM)

DTILN/A

ELDNN/A

Net Debt/EBITDA (TTM)

DTIL0.00x

ELDN0.00x

Beta

DTIL1.44

ELDN1.01

52W Performance

DTIL17.9%

ELDN-13.6%

YTD Performance

DTIL63.9%

ELDN53.1%

% from 52W High

DTIL-30.1%

ELDN-46.1%

% from 52W Low

DTIL90.4%

ELDN83.7%

Asset Turnover (TTM)

DTIL0.36x

ELDN0.00x

FCF Yield (TTM)

DTIL-30.2%

ELDN-38.6%

Earnings Yield (TTM)

DTIL-30.4%

ELDN-51.5%

Dividend Yield (TTM)

DTILN/A

ELDNN/A

Rule of 40

DTIL3,356.7

ELDN0.0

EV/GP/RG

DTILN/A

ELDNN/A

Ticker research

View DTIL research View ELDN research

Metric	DTIL Precision BioSciences Inc	ELDN Eledon Pharmaceuticals Inc
Market & Valuation
Market Cap	$173M	$191M
Enterprise Value	$110M	$185M
Price	$6.72	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	3.85x	0.00x
EV/Sales	2.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.85x	2.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.09x	-2.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	80.94x	N/A
Revenue & Growth
Revenue (TTM)	$45M	$0
Revenue Growth (YoY)	3473.0%	N/A
Forward Rev Growth	-28.2%	325.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-78.0%	0.0%
Net Margin (TTM)	-117.0%	0.0%
FCF Margin (TTM)	-116.3%	N/A
Net Income (TTM)	$-53M	$-99M
FCF (TTM)	$-52M	$-74M
EPS (TTM)	-$2.04	-$0.87
ROE (TTM)	-9160.0%	-9848.0%
ROA (TTM)	-4074.0%	-6897.0%
ROIC (TTM)	-6594.0%	-9848.0%
Financial Health
Cash	$86M	$7M
Debt	$22M	$0
Net Cash/Debt	$64M	$7M
Current Ratio (TTM)	12.82x	7.90x
Quick Ratio (TTM)	12.26x	7.60x
Debt/Equity (TTM)	0.50x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.01
52W Performance	17.9%	-13.6%
YTD Performance	63.9%	53.1%
% from 52W High	-30.1%	-46.1%
% from 52W Low	90.4%	83.7%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-30.2%	-38.6%
Earnings Yield (TTM)	-30.4%	-51.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,356.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DTIL research	View ELDN research